Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Sales (2016 - 2025)

Historic Return on Sales for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to 1.04%.

  • CorMedix's Return on Sales rose 12800.0% to 1.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76%, marking a year-over-year increase of 41200.0%. This contributed to the annual value of 0.41% for FY2024, which is 13953000.0% down from last year.
  • According to the latest figures from Q3 2025, CorMedix's Return on Sales is 1.04%, which was up 12800.0% from 0.5% recorded in Q2 2025.
  • In the past 5 years, CorMedix's Return on Sales ranged from a high of 1926.78% in Q2 2023 and a low of 1005.39% during Q3 2022
  • Moreover, its 5-year median value for Return on Sales was 8.9% (2024), whereas its average is 97.76%.
  • Per our database at Business Quant, CorMedix's Return on Sales skyrocketed by 22846100bps in 2023 and then tumbled by -19443300bps in 2024.
  • Quarter analysis of 5 years shows CorMedix's Return on Sales stood at 138.15% in 2021, then plummeted by -100bps to 276.38% in 2022, then soared by 369bps to 743.11% in 2023, then tumbled by -100bps to 0.43% in 2024, then surged by 141bps to 1.04% in 2025.
  • Its Return on Sales stands at 1.04% for Q3 2025, versus 0.5% for Q2 2025 and 0.53% for Q1 2025.